Betűméret: A A A

Tudományos program

Preliminary Program

9th November 2017.

09.00 Opening Ceremony
09.15-13.00 Section I.
Emerging viral infections

Dóra Szabó
Institute of Medical Microbiology, Semmelweis University, Hungary
History of the Medical Microbiology Institute
József Ongrádi
Institute of Medical Microbiology, Semmelweis University, Hungary
Adenovirus research at SOTE Microbiology Institute
Orsolya Dobay
Institute of Medical Microbiology, Semmelweis University, Hungary
The Adenovirus Research Group of the Hungarian Academy of Sciences, 1995-1998
Dario Di Luca
University of Ferrara, Italy
HHV-6 and inhibitory KIR2DL2 NK cell receptor
József Ongrádi
Institute of Medical Microbiology, Semmelweis University, Hungary
In vitro studies on the immunomodulatory aspects of HHV-6 and HHV-7

11.00-11.20 Coffee Break

Davide Abate
Unverstiy of Padova, Italy
New challenges in CMV infections
Erwin Tschachler
Vienna, Austria
The 35 years of HIV/AIDS –What next?
Károly Nagy
Institute of Medical Microbiology, Semmelweis University, Hungary
Contribution of advanced molecular biology to the HIV surveillance in Hungary

13.00-14.00 Lunch

14.00-17.00 Section I.
Emerging viral infections pt. 2

Anna-Bella Failloux
Institut Pasteur, Paris, France
New challanges in Arbo-Roboinfection
Zoltán Kis
National Center for Epidemiology, Hungary
The Ebola outbreak – is it over?
Orsolya Nagy
National Center for Epidemiology, Hungary
Laboratory diagnosis of Zika virus

11.00-11.20 Coffee Break

Mária Takács
National Center for Epidmeiology, Hungary
Hepatitis B and C serotypes in Hungary
László Rókusz
National Healthcare Services Center, Hungary
The experience with the treatment of hepatitis C infection
Csaba Jeney
Institute of Medical Microbiology, Semmelweis University, Hungary
The evolution of molecular diagnostic in HPV

18.00 Offical Dinner

10th November 2017.

8.00-10.40 Section II.
The challenges of the multidrug resistant bacteria and new therapeutic approaches

Christian Giske
Karolinska Institute, Stockholm, Sweden
Global trends in the antimicrobial resistance
Béla Kocsis
Institute of Medical Microbiology, Semmelweis University, Hungary
Multidrug resistant Gram-negative bacteria in Hungary
Ákos Tóth
National Center for Epidemiology, Hungary
Multi-drug resistant Gram-positive bacteria in Hungary
Mark van der Linden
Germany
Global trends in the seroprevalence in Streptococus pneumoniae
Orsolya Dobay
Institute of Medical Microbiology, Semmelweis University, Hungary
Pneumococci carried by healthy children in Hungary, 2009-2015
Endre Ludwig
Joined Saint Stephan and Saint Ladislaus Hospital-Clinic, Budapest, Hungary
Antibiotic therapy in the age of multiresistant bugs – a clinician’s approach
Miklós Füzi
Institute of Medical Microbiology, Semmelweis University, Hungary
Dissimilar fitness associated with resistance to fluoroquinolones influences clonal dynamics of various multiresistant bacteria

10.40-11.00 Coffee break

11.00-13.00 Section II.
The challenges of the multidrug resistant bacteria and new therapeutic approaches pt. 2

Carl Kraus
Raleigh-Durham, USA
FDA Pathways to Antibiotic Approval
Ralf Hoffmann
Leipzig, Germany
The mechanims of the short proline-rich antimicrobial peptides
László Ötvös
Temple University, Philadelphia, USA
Are the peptid antibiotics the future?
Eszter Ostorházi
Institute of Medical Microbiology, Semmelweis University, Hungary
Experiences with the A3-APO

13.00-14.00 Lunch

14.00-17.00 Section III.
The importance of the human microbiome

Sean Kennedy
Institut Pasteur, Paris, France
The bioinformatical analysis of the microbiome
Dóra Szabó
Institute of Medical Microbiology, Semmelweis University, Hungary
The effect of the antibiotics on the microbiome
Zsolt Radák
University of Physical Education, Hungary
The sport and the microbiome

15.30-15.40 Coffee break

Krisztina Madách
Semmelweis University, Hungary
The role of the microbiome in the intensive care
Gábor Veres
Semmelweis University, Hungary
The role of microbiome in Chron’s disease
Sándor Pongor
Péter Pázmány Catholic University, Hungary
The role of the horizontal gene transfer in the microbiome
Dóra Szabó
Institute of Medical Microbiology, Semmelweis University, Hungary
Closing remarks

Test